The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...
GB Logistics Commerce IPO opened for subscription on January 24, attracting strong investor interest. The IPO aims to raise ₹25 crore, with shares priced between ₹95 and ₹102. Listing on BSE SME is ...
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...
The issue will open its window for bidding from January 29 to January 31, with the anchor investor bidding set to begin on ...
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback